Brian Ma
About Brian Ma
Brian Ma is a Senior Clinical Projects Associate at Nektar Therapeutics, with over five years of experience in the immuno-oncology field. He holds a BS in Organic Chemistry from the University of California, Berkeley, and has previously worked in various research and educational roles.
Work at Nektar Therapeutics
Brian Ma currently holds the position of Senior Clinical Projects Associate at Nektar Therapeutics, where he has been employed since 2021. In this role, he focuses on managing clinical projects that aim to enhance patient health outcomes. His responsibilities include overseeing clinical trial processes and ensuring compliance with regulatory standards. His experience in the immuno-oncology space informs his work, particularly in the development of investigational agents.
Education and Expertise
Brian Ma earned a Bachelor of Science degree in Organic Chemistry from the University of California, Berkeley, where he studied from 2009 to 2013. His academic background provides a strong foundation for his work in clinical research, particularly in the fields of immuno-oncology and small molecule therapeutics. He has over five years of experience in clinical trials and research, focusing on translating this expertise to improve access to FDA-approved medications.
Background
Brian Ma's professional journey includes diverse roles in education and clinical research. He served as an Assistant Language Teacher with the Japan Exchange and Teaching Program(me) in Ishikawa, Japan, from 2014 to 2015. He also worked at the University of California, San Francisco in various capacities, including Interim Clinical Research Manager and Research Assistant. His early career involved tutoring organic chemistry and conducting research in the Department of Radiology.
Achievements
Throughout his career, Brian Ma has contributed to various research initiatives and clinical projects. His work in the immuno-oncology space has been significant, focusing on bench-to-bedside investigational agents. He has aimed to leverage his clinical trial experience to enhance patient health outcomes and improve access to medications. His roles at UCSF and Nektar Therapeutics reflect his commitment to advancing healthcare research.